Dr. Noah Biotech (닥터노아바이오텍)
Suwon, South Korea
DR.NOAH Biotech is the next-generation pharmaceutical company that seeks efficient new drug development based on big data analysis medicine and artificial intelligence technology. Based on the world's best drug forecasting technology, the company aims to develop the world's first treatment for rare genetic diseases. The new Orphan Drug Market is a growing market and an area of high investment value. There are more than 7,000 rare diseases, but more than 90 percent of them do not have proper drugs yet. It would take more than 500 years to develop the new drug at the current rate of development for the rare disease. DR.NOAH Biotech will be able to complete the prediction of orphan drug within 3 months by utilizing the technology to complete the development of the medication in a short time more efficiently than the conventional method.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2016
- Website
- www.drnoahbiotech.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Dr. Noah Biotech (닥터노아바이오텍)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now